Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial

BACKGROUND: Currently, there are no specific effective treatments for SARS-CoV-2 infection; however, various COVID-19 treatment options are under investigation. It is vital to continue investigating the landscape of SARS-CoV-2–induced pneumonia and therapeutic interventions. OBJECTIVE: This paper pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada-Hirashima, Junko, Suzuki, Manabu, Uemura, Yukari, Hojo, Masayuki, Mikami, Ayako, Sugiura, Wataru, Ohmagari, Norio, Sugiyama, Haruhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781585/
https://www.ncbi.nlm.nih.gov/pubmed/33206053
http://dx.doi.org/10.2196/23830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781585/
https://www.ncbi.nlm.nih.gov/pubmed/33206053
http://dx.doi.org/10.2196/23830

Ejemplares similares